Subjects received one-time administration of a highly optimized gene therapy at initial low dose without the need for immunosuppression Therapeutic...
Read moreMallinckrodt plc a leading global specialty biopharmaceutical company, today confirmed enrollment of the first patient in the company's Phase 4...
Read moreAstraZeneca announced that benralizumab, a potential new medicine and anti-eosinophil monoclonal antibody, was well tolerated and achieved the primary endpoint...
Read moreAstraZeneca announced that benralizumab, a potential new medicine and anti-eosinophil monoclonal antibody, was well tolerated and achieved the primary endpoint...
Read moreAllergan plc announced that two pivotal trials of the Oculeve Intranasal Tear Neurostimulator, OCUN-009 and OCUN-010, each met their primary...
Read moreMerck, known as MSD outside the United States and Canada, announced that the U.S. FDA has granted Breakthrough Therapy Designation...
Read moreThis whitepaper highlights some of the most advanced companies in their innovative approaches to trial recruitment. Witness first-hand 5 case...
Read moreAbbVie (NYSE: ABBV), a global biopharmaceutical company, today announced the online publication of new data in the New England Journal...
Read moreAbbVie , a global biopharmaceutical company, announced preliminary data from the ongoing Phase 1/2b PCYC-1119 trial suggesting that the combination of...
Read more- IMBRUVICA ASSOCIATED WITH SIGNIFICANT IMPROVEMENTS IN KEY ENDPOINTS INCLUDING REDUCTION OF THE RISK OF DISEASE PROGRESSION OR DEATH VERSUS...
Read more
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
